secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2022-11-15T23:59:59+00:00
Accession:  0001193125-22-285792
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma raises $30M in PIPE financing; sells shares, pre-funded warrants, and warrants
--------------------------------------------------------------------------------

- Gross proceeds of $30M; net proceeds ~$28.2M after fees.
- Issued 7,656,966 shares, pre-funded warrants for 1,531,440 shares, and warrants for up to 9,188,406 shares at $3.265/unit.
- Warrant exercise price $3.93, exercisable for 5 years; pre-funded warrants exercisable indefinitely.
- Proceeds to fund CUE-101 clinical development, business development, working capital.
- Closing expected Nov 16, 2022; Piper Sandler and Public Ventures as placement agents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522285792/0001193125-22-285792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522285792/d420848d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-285792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer